Axcan Pharma to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London, UK

Axcan Pharma Inc. ("Axcan" or the "Company") (TSX: AXP)(NASDAQ: AXCA) today announced that on Tuesday, September 18, 2007, President and Chief Executive Officer, Frank Verwiel, M.D., will present an overview of the Company at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference to be held in London, U.K. This presentation will take place at 3.20 p.m. local time (10.20 a.m. Eastern time).

A webcast of Axcan's presentation will also be accessible via the Company's website at


Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Axcan Pharma Inc.
Isabelle Adjahi
Senior Director, Investor Relations and Communications
450-467-2600 ext. 2000

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.